Literature DB >> 23063604

Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony.

Rodrigo Medeiros1, Frank M LaFerla.   

Abstract

Alzheimer disease (AD) is the most prevalent cause of dementia in humans, and the symptoms are commonly manifested after the seventh decade of life. Numerous pathological changes have been described in the postmortem brains of AD patients, including senile plaques, neurofibrillary tangles, neuroinflammation, synapse loss, and neuronal death. Reactive astrocytes surrounding senile plaques seem to be responsible for the ongoing inflammatory process in the disease through the release of cytokines and other toxic products. However, little is known about the regulation of these cells in the AD brain. Here we discuss the potential translational impact of the recent findings of Carrero and colleagues, published in Experimental Neurology, that shows the underlying molecular mechanism of astrocyte activation in response to β-amyloid (Aβ). Likewise, the relevance of pro-inflammatory mediators tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), cyclooxygenase-2 (COX-2) and nuclear factor-κB (NF-κB), as integral players in disease progression will be discussed.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23063604     DOI: 10.1016/j.expneurol.2012.10.007

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  73 in total

1.  Lipolysaccharide-Induced Neuroinflammation Is Associated with Alzheimer-Like Amyloidogenic Axonal Pathology and Dendritic Degeneration in Rats.

Authors:  Xiaohua Deng; Meili Li; Weiming Ai; Lixin He; Dahua Lu; Peter R Patrylo; Huaibin Cai; Xuegang Luo; Zhiyuan Li; Xiaoxin Yan
Journal:  Adv Alzheimer Dis       Date:  2014-06

Review 2.  An endothelial link between the benefits of physical exercise in dementia.

Authors:  Lianne J Trigiani; Edith Hamel
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-15       Impact factor: 6.200

Review 3.  The role of glia in stress: polyamines and brain disorders.

Authors:  Serguei N Skatchkov; Michel A Woodbury-Fariña; Misty Eaton
Journal:  Psychiatr Clin North Am       Date:  2014-11-25

4.  Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain.

Authors:  Zhi Xiong; Ramasamy Thangavel; Duraisamy Kempuraj; Evert Yang; Smita Zaheer; Asgar Zaheer
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 5.  Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?

Authors:  Antoine Louveau; Sandro Da Mesquita; Jonathan Kipnis
Journal:  Neuron       Date:  2016-09-07       Impact factor: 17.173

6.  Haptoglobin modulates beta-amyloid uptake by U-87 MG astrocyte cell line.

Authors:  Bernardetta Maresca; Maria Stefania Spagnuolo; Luisa Cigliano
Journal:  J Mol Neurosci       Date:  2014-11-18       Impact factor: 3.444

7.  Mesenchymal Stem Cells Therapy Improved the Streptozotocin-Induced Behavioral and Hippocampal Impairment in Rats.

Authors:  María F Zappa Villar; Juliette López Hanotte; Joaquín Pardo; Gustavo R Morel; Guillermo Mazzolini; Mariana G García; Paula C Reggiani
Journal:  Mol Neurobiol       Date:  2019-08-10       Impact factor: 5.590

Review 8.  Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

9.  APOE genotype-dependent modulation of astrocyte chemokine CCL3 production.

Authors:  Eiron Cudaback; Yue Yang; Thomas J Montine; C Dirk Keene
Journal:  Glia       Date:  2014-08-04       Impact factor: 7.452

10.  Atorvastatin Attenuates Cognitive Deficits and Neuroinflammation Induced by Aβ1-42 Involving Modulation of TLR4/TRAF6/NF-κB Pathway.

Authors:  Shan Wang; Xiaowei Zhang; Liuyu Zhai; Xiaona Sheng; Weina Zheng; Hongshan Chu; Guohua Zhang
Journal:  J Mol Neurosci       Date:  2018-02-07       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.